MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ERWIN, V. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ERWIN, V. G.

Molecular Pharmacology, Vol 5, 615-624, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics

Enhancement of Brain Glutamate Dehydrogenase Activity and Glutamate Oxidation by Adenine Nucleotides

V. GENE ERWIN 1

1 School of Pharmacy, University of Colorado, Boulder, Colorado 80302

The rate of oxidation of glutamate by brain homogenates or mitochondria was enhanced approximately 4-fold by 5'-AMP, cyclic 3',5'-AMP, or 5'-ADP. These nucleotides were equally effective in augmenting glutamate oxidation, while 3'-AMP, 2'-AMP, and 2',3'-AMP were without effect. Cyclic 3',5'-AMP did not increase the rate of glutamate oxidation in heart or testis homogenates but produced 13% and 89% stimulation by liver and kidney homogenates, respectively. Kinetic and gel filtration evidence indicates that glutamate dehydrogenases of brain, liver, and kidney mitochondria are not identical in their properties. The enhancement of activity of the brain enzyme by 5'-AMP or cyclic 3',5'-AMP was dependent on the pH of the reaction mixture and the concentration of NAD. At pH 8.0, the apparent Km for NAD was decreased from 2 mM in the absence of adenine nucleotides to 0.4 mM or 0.5 mM in the presence of 5'-AMP or cyclic 3',5'-AMP, respectively. At pH 7.5, 5'-AMP evoked twice the stimulation produced by corresponding concentrations of cyclic 3',5'-AMP. Kinetic evidence indicates that brain glutamate dehydrogenase contains at least two cooperative sites for NAD in the absence of adenine nucleotides, and only one site in the presence of these activators. Density gradient studies suggest that the molecular weight of the activated enzyme is approximately 250,000.

Submitted on June 13, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics